Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis

Akinori Morita, Shinya Ariyasu, Soichiro Ohya, Ippei Takahashi, Bing Wang, Kaoru Tanaka, Takatoshi Uchida, Haruna Okazaki, Kengo Hanaya, Atsushi Enomoto, Mitsuru Nenoi, Masahiko Ikekita, Shin Aoki, Yoshio Hosoi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

In a previous study, we reported that sodium orthovanadate (vanadate) is the first known inhibitor that is capable of protecting mice from death from the radiation-induced gastrointestinal syndrome via its ability to block both transcription-dependent and transcription-independent p53 apoptotic pathways. In this paper, we report that vanadate has a unique activity for inducing the denaturation of p53 relative to other known radioprotective p53 inhibitors, pifithrin-α (PFTα) and pifithrin-μ (PFTμ). This potent radioprotective effect of vanadate prompted us to undertake a more extensive search for p53 inhibitors that can induce p53 denaturation. Based on the fact that p53 denaturation can be induced by the dissociation of a zinc ion, which is used as a structural factor of p53, we screened some zinc (II) chelators for the suppression of the DNA binding activity of p53 in vitro and the inhibition of radiation-induced p53-dependent apoptosis in MOLT-4 cells. The findings indicate that two of five zinc (II) chelators also suppressed apoptosis. Among the inhibitors tested, Bispicen (N,N'-Bis(2-pyridylmethyl)-1,2-ethanediamine) had the highest inhibition activity. A mechanistic study using cells bearing different p53 status or functions (i.e., p53-knockdown MOLT-4 transformant and its revertants, p53 mutant cells, p53-null cells), and p53-independent apoptotic stimuli revealed that the suppressive effect of Bispicen on apoptosis is specifically mediated through p53. Moreover, Bispicen, similar to vanadate, induces the denaturation of p53 as well as the blocking of both transcription-dependent and -independent apoptotic pathways. Our findings indicate that the use of zinc (II) chelators represent a new approach for protecting against radiation-induced p53-dependent apoptosis through the inhibition of p53-dependent apoptotic pathways.

Original languageEnglish
Pages (from-to)2439-2450
Number of pages12
JournalOncotarget
Volume4
Issue number12
Publication statusPublished - 2013 Dec
Externally publishedYes

Fingerprint

Vanadates
Chelating Agents
Zinc
Apoptosis
ethylenediamine
Radiation
Null Lymphocytes
Ions
DNA

Keywords

  • Apoptosis
  • p53
  • Radiation
  • Zinc binding site
  • Zinc chelator

ASJC Scopus subject areas

  • Oncology

Cite this

Morita, A., Ariyasu, S., Ohya, S., Takahashi, I., Wang, B., Tanaka, K., ... Hosoi, Y. (2013). Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis. Oncotarget, 4(12), 2439-2450.

Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis. / Morita, Akinori; Ariyasu, Shinya; Ohya, Soichiro; Takahashi, Ippei; Wang, Bing; Tanaka, Kaoru; Uchida, Takatoshi; Okazaki, Haruna; Hanaya, Kengo; Enomoto, Atsushi; Nenoi, Mitsuru; Ikekita, Masahiko; Aoki, Shin; Hosoi, Yoshio.

In: Oncotarget, Vol. 4, No. 12, 12.2013, p. 2439-2450.

Research output: Contribution to journalArticle

Morita, A, Ariyasu, S, Ohya, S, Takahashi, I, Wang, B, Tanaka, K, Uchida, T, Okazaki, H, Hanaya, K, Enomoto, A, Nenoi, M, Ikekita, M, Aoki, S & Hosoi, Y 2013, 'Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis', Oncotarget, vol. 4, no. 12, pp. 2439-2450.
Morita A, Ariyasu S, Ohya S, Takahashi I, Wang B, Tanaka K et al. Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis. Oncotarget. 2013 Dec;4(12):2439-2450.
Morita, Akinori ; Ariyasu, Shinya ; Ohya, Soichiro ; Takahashi, Ippei ; Wang, Bing ; Tanaka, Kaoru ; Uchida, Takatoshi ; Okazaki, Haruna ; Hanaya, Kengo ; Enomoto, Atsushi ; Nenoi, Mitsuru ; Ikekita, Masahiko ; Aoki, Shin ; Hosoi, Yoshio. / Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis. In: Oncotarget. 2013 ; Vol. 4, No. 12. pp. 2439-2450.
@article{6f392ce00553493690f4a675ffe87ade,
title = "Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis",
abstract = "In a previous study, we reported that sodium orthovanadate (vanadate) is the first known inhibitor that is capable of protecting mice from death from the radiation-induced gastrointestinal syndrome via its ability to block both transcription-dependent and transcription-independent p53 apoptotic pathways. In this paper, we report that vanadate has a unique activity for inducing the denaturation of p53 relative to other known radioprotective p53 inhibitors, pifithrin-α (PFTα) and pifithrin-μ (PFTμ). This potent radioprotective effect of vanadate prompted us to undertake a more extensive search for p53 inhibitors that can induce p53 denaturation. Based on the fact that p53 denaturation can be induced by the dissociation of a zinc ion, which is used as a structural factor of p53, we screened some zinc (II) chelators for the suppression of the DNA binding activity of p53 in vitro and the inhibition of radiation-induced p53-dependent apoptosis in MOLT-4 cells. The findings indicate that two of five zinc (II) chelators also suppressed apoptosis. Among the inhibitors tested, Bispicen (N,N'-Bis(2-pyridylmethyl)-1,2-ethanediamine) had the highest inhibition activity. A mechanistic study using cells bearing different p53 status or functions (i.e., p53-knockdown MOLT-4 transformant and its revertants, p53 mutant cells, p53-null cells), and p53-independent apoptotic stimuli revealed that the suppressive effect of Bispicen on apoptosis is specifically mediated through p53. Moreover, Bispicen, similar to vanadate, induces the denaturation of p53 as well as the blocking of both transcription-dependent and -independent apoptotic pathways. Our findings indicate that the use of zinc (II) chelators represent a new approach for protecting against radiation-induced p53-dependent apoptosis through the inhibition of p53-dependent apoptotic pathways.",
keywords = "Apoptosis, p53, Radiation, Zinc binding site, Zinc chelator",
author = "Akinori Morita and Shinya Ariyasu and Soichiro Ohya and Ippei Takahashi and Bing Wang and Kaoru Tanaka and Takatoshi Uchida and Haruna Okazaki and Kengo Hanaya and Atsushi Enomoto and Mitsuru Nenoi and Masahiko Ikekita and Shin Aoki and Yoshio Hosoi",
year = "2013",
month = "12",
language = "English",
volume = "4",
pages = "2439--2450",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "12",

}

TY - JOUR

T1 - Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis

AU - Morita, Akinori

AU - Ariyasu, Shinya

AU - Ohya, Soichiro

AU - Takahashi, Ippei

AU - Wang, Bing

AU - Tanaka, Kaoru

AU - Uchida, Takatoshi

AU - Okazaki, Haruna

AU - Hanaya, Kengo

AU - Enomoto, Atsushi

AU - Nenoi, Mitsuru

AU - Ikekita, Masahiko

AU - Aoki, Shin

AU - Hosoi, Yoshio

PY - 2013/12

Y1 - 2013/12

N2 - In a previous study, we reported that sodium orthovanadate (vanadate) is the first known inhibitor that is capable of protecting mice from death from the radiation-induced gastrointestinal syndrome via its ability to block both transcription-dependent and transcription-independent p53 apoptotic pathways. In this paper, we report that vanadate has a unique activity for inducing the denaturation of p53 relative to other known radioprotective p53 inhibitors, pifithrin-α (PFTα) and pifithrin-μ (PFTμ). This potent radioprotective effect of vanadate prompted us to undertake a more extensive search for p53 inhibitors that can induce p53 denaturation. Based on the fact that p53 denaturation can be induced by the dissociation of a zinc ion, which is used as a structural factor of p53, we screened some zinc (II) chelators for the suppression of the DNA binding activity of p53 in vitro and the inhibition of radiation-induced p53-dependent apoptosis in MOLT-4 cells. The findings indicate that two of five zinc (II) chelators also suppressed apoptosis. Among the inhibitors tested, Bispicen (N,N'-Bis(2-pyridylmethyl)-1,2-ethanediamine) had the highest inhibition activity. A mechanistic study using cells bearing different p53 status or functions (i.e., p53-knockdown MOLT-4 transformant and its revertants, p53 mutant cells, p53-null cells), and p53-independent apoptotic stimuli revealed that the suppressive effect of Bispicen on apoptosis is specifically mediated through p53. Moreover, Bispicen, similar to vanadate, induces the denaturation of p53 as well as the blocking of both transcription-dependent and -independent apoptotic pathways. Our findings indicate that the use of zinc (II) chelators represent a new approach for protecting against radiation-induced p53-dependent apoptosis through the inhibition of p53-dependent apoptotic pathways.

AB - In a previous study, we reported that sodium orthovanadate (vanadate) is the first known inhibitor that is capable of protecting mice from death from the radiation-induced gastrointestinal syndrome via its ability to block both transcription-dependent and transcription-independent p53 apoptotic pathways. In this paper, we report that vanadate has a unique activity for inducing the denaturation of p53 relative to other known radioprotective p53 inhibitors, pifithrin-α (PFTα) and pifithrin-μ (PFTμ). This potent radioprotective effect of vanadate prompted us to undertake a more extensive search for p53 inhibitors that can induce p53 denaturation. Based on the fact that p53 denaturation can be induced by the dissociation of a zinc ion, which is used as a structural factor of p53, we screened some zinc (II) chelators for the suppression of the DNA binding activity of p53 in vitro and the inhibition of radiation-induced p53-dependent apoptosis in MOLT-4 cells. The findings indicate that two of five zinc (II) chelators also suppressed apoptosis. Among the inhibitors tested, Bispicen (N,N'-Bis(2-pyridylmethyl)-1,2-ethanediamine) had the highest inhibition activity. A mechanistic study using cells bearing different p53 status or functions (i.e., p53-knockdown MOLT-4 transformant and its revertants, p53 mutant cells, p53-null cells), and p53-independent apoptotic stimuli revealed that the suppressive effect of Bispicen on apoptosis is specifically mediated through p53. Moreover, Bispicen, similar to vanadate, induces the denaturation of p53 as well as the blocking of both transcription-dependent and -independent apoptotic pathways. Our findings indicate that the use of zinc (II) chelators represent a new approach for protecting against radiation-induced p53-dependent apoptosis through the inhibition of p53-dependent apoptotic pathways.

KW - Apoptosis

KW - p53

KW - Radiation

KW - Zinc binding site

KW - Zinc chelator

UR - http://www.scopus.com/inward/record.url?scp=84891939016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891939016&partnerID=8YFLogxK

M3 - Article

C2 - 24280450

AN - SCOPUS:84891939016

VL - 4

SP - 2439

EP - 2450

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 12

ER -